articles about PCV2 in Swine news

The Chilean pig sector is still improving in the strengthening of animal health through the implementation of prevention, control and eradication programmes.

The talks were devoted to the discussion of vital issues related to cooperation between the countries in veterinary surveillance and assurance of biological safety of mutually delivered animal products.

Researchers of CReSA and CENSA have developed a real-time PCR system for the detection and differentiation of PCV-2, PRV1, PPV and TTSuV1 and TTSuV2.

The Veterinary Laboratories Agency (VLA) is to increase surveillance for PCV2 virus as a cause of reproductive failure in cases of abortion and stillbirth where no other infectious cause has been identified.

A vaccine against porcine circovirus (PCV) has been successfully developed in Henan Province and granted the National Registration Certificate for New Veterinary Drug and the production approval document number as well as the approval to be marketed as a national-level new veterinary drug of the second category from the Ministry of Agriculture (MOA).

This disease is costing the Canadian pork industry about 60 million dollars a year.

PORCIVIR is a project coordinated by CReSA for the study of swine viral diseases that have economic, sanitary and public health repercussions. PORCIVIR has an exclusive website available, in which you will be able to consult any information in relation to the project, including the last publications.

The federal government has made changes to its eligibility criteria for the Circovirus Inoculation Program. Applicants deemed to be part of a verifiable production flow will now receive compensation for the vaccination of sows.